Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Application of the Haemostatic Solution "Haemoblock" to Reduce the Risk of Pacemaker Pocket Hematoma

NCT04559646 is registered in ClinicalTrials.gov with Ryazan State Medical University as lead sponsor.

NCT NCT04559646
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04559646 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Application of the Haemostatic Solution "Haemoblock" to Reduce the Risk of Pacemaker Pocket Hematoma
Lead sponsor
Ryazan State Medical University
Phase
Observational
Overall status
Completed
Start date
January 1, 2021
Completion date
November 1, 2023
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hematoma postoperative